Previous Close | 1.17 |
1-Year Change | 108.93% |
6-Months Change | 51.95% |
3-Months Change | -45.83% |
Moving Avg (50d) | 1.7458 |
Moving Avg (200d) | 1.0788 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 207.3M |
Beta (3-Years) | 1.81 |
Revenue Growth (ttm) | 79.75% |
Net Profit Margin (ttm) | -123.89% |
Return On Assets (ttm) | -113.58% |
EPS (ttm) | -1.45 |
PE Ratio (ttm) | -0.81 |
Dividend Yield | % |
Asset Description: | Sangamo Therapeutics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2025-01-30 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.147 | 1.111 | 1.088 | 1.053 | 0.994 | 0.936 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.